Related Experiment Videos

Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents

Insights

This study assessed antimicrobial susceptibility in Campylobacter fetus subsp. jejuni. Doxycycline and gentamicin showed the best activity, while resistance to beta-lactams, metronidazole, and tinidazole was observed in some strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Campylobacter fetus subsp. jejuni is a significant cause of bacterial gastroenteritis.
  • Understanding antimicrobial susceptibility patterns is crucial for effective treatment.
  • Emerging resistance necessitates ongoing surveillance of clinical isolates.

Purpose of the Study:

  • To determine the in vitro antimicrobial susceptibility of recent clinical isolates of Campylobacter fetus subsp. jejuni.
  • To identify effective antimicrobial agents against this pathogen.
  • To assess the prevalence of resistance to commonly used antibiotics.

Main Methods:

  • Agar dilution technique was employed.
  • One hundred recent clinical isolates of Campylobacter fetus subsp. jejuni were tested.
  • Susceptibility to 20 different antimicrobial agents was evaluated.

Main Results:

  • Doxycycline and gentamicin demonstrated potent activity, inhibiting all tested strains at achievable serum concentrations.
  • Erythromycin exhibited low median minimal inhibitory concentration, but 8% of isolates displayed high resistance.
  • All isolates showed relative resistance to beta-lactam antibiotics.
  • Significant resistance to metronidazole and tinidazole was noted in some strains.

Conclusions:

  • Doxycycline and gentamicin are promising therapeutic options for Campylobacter fetus subsp. jejuni infections.
  • The emergence of erythromycin resistance warrants careful monitoring.
  • Resistance to beta-lactams, metronidazole, and tinidazole highlights the need for judicious antibiotic selection.

Related Concept Videos